In accordance with Provisions for Drug Registration, the State Food and Drug Administration (SFDA) recently issued an announcement on February 1, which specifying and further standardize relevant requirements on: application, acceptance, approval of import drug re-registration and repackaging; archive checking procedure of re-registration; temporary import and repackaging during re-registration; supplementary application related to re-registration; issuance of re-registration and supplementary application license etc.